 
FDA Posts Summary on Virtual Public Meeting and Listening Sessions on Food Allergen Thresholds and Their Potential Applications
On February 18-20, 2026, the FDA held a virtual public meeting and listening sessions on food allergen thresholds and their potential applications.
The FDA hosted the virtual public meeting with all stakeholders to help inform next steps and develop strategies for applying allergen thresholds to benefit public health.
The purpose of the listening sessions was for individuals and organizations to share ideas and perspectives on the potential adoption of a science-based food allergen threshold framework in the United States. The FDA created a summary of key themes from information shared by participants.
The FDA will review the input received at the public meeting, in listening sessions, and in response to a Regulations.gov docket to determine next steps and prioritize potential options.
About Us
The Public Engagement Staff resides within the Office of Operations and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, patients and patient advocacy organizations, consumer groups, trade associations, think tanks and academia, and other interested parties, in order to better inform our policy making process, identify policy hurdles or misconceptions, and create strategic collaborations. For more information, please contact us at PublicEngagement@fda.hhs.gov. For patient specific inquiries, please contact us at Patients Ask FDA.
|
